Tower Research Capital (TRC)’s Invacare Corporation IVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-526
Closed -$1K 6823
2022
Q2
$1K Sell
526
-19,898
-97% -$26.2K ﹤0.01% 5967
2022
Q1
$29K Buy
20,424
+13,108
+179% +$28K ﹤0.01% 3209
2021
Q4
$20K Buy
7,316
+5,062
+225% +$18.7K ﹤0.01% 3698
2021
Q3
$11K Sell
2,254
-3,311
-59% -$24.2K ﹤0.01% 4282
2021
Q2
$45K Sell
5,565
-34,817
-86% -$290K ﹤0.01% 3117
2021
Q1
$324K Buy
40,382
+21,583
+115% +$201K 0.01% 1615
2020
Q4
$169K Sell
18,799
-29,028
-61% -$241K 0.01% 1856
2020
Q3
$359K Buy
47,827
+36,122
+309% +$250K ﹤0.01% 2018
2020
Q2
$75K Buy
+11,705
New +$78.3K ﹤0.01% 2718
2019
Q4
Sell
-6,270
Closed -$47K 4642
2019
Q3
$47K Buy
+6,270
New +$35.2K ﹤0.01% 1845
2019
Q2
Sell
-5,752
Closed -$48K 4516
2019
Q1
$48K Buy
+5,752
New +$41.4K ﹤0.01% 1788
2018
Q3
Sell
-700
Closed -$13K 4397
2018
Q2
$13K Buy
700
+620
+775% +$11.2K ﹤0.01% 2681
2018
Q1
$1K Buy
+80
New +$1.41K ﹤0.01% 3129
2017
Q4
Sell
-968
Closed -$15K 4200
2017
Q3
$15K Buy
+968
New +$13.8K ﹤0.01% 2899
2017
Q1
Sell
-233
Closed -$3K 4153
2016
Q4
$3K Buy
+233
New +$2.68K ﹤0.01% 3314
2016
Q1
Sell
-300
Closed -$5K 5179
2015
Q4
$5K Sell
300
-669
-69% -$12.1K ﹤0.01% 3045
2015
Q3
$14K Sell
969
-3,155
-77% -$55.2K ﹤0.01% 2056
2015
Q2
$89K Buy
4,124
+3,060
+288% +$64.8K 0.01% 941
2015
Q1
$21K Buy
+1,064
New +$18.4K ﹤0.01% 2216
2014
Q4
Sell
-1,099
Closed -$13K 4891
2014
Q3
$13K Buy
+1,099
New +$16.8K ﹤0.01% 2656
2014
Q2
Sell
-1,564
Closed -$30K 4791
2014
Q1
$30K Buy
+1,564
New +$32.2K ﹤0.01% 1509
2013
Q4
Sell
-3,439
Closed -$59K 5028
2013
Q3
$59K Buy
+3,439
New +$54.6K 0.01% 1767

Other funds holding IVC

Tower Research Capital (TRC)'s IVC Position: Q3 2022 in Review

Tower Research Capital (TRC) sold out of Invacare Corporation (IVC) in Q3 2022, closing a stake of 526 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in IVC in Q3 2013 and held it in 22 quarters. The position peaked at $359K in Q3 2020. 72 funds tracked by Wall St. Rank hold IVC as of Q3 2022.

  • Tower Research Capital (TRC) reported no remaining Invacare Corporation position as of Q3 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 526 Invacare Corporation shares in Q3 2022, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in Invacare Corporation in Q3 2013 and held it in 22 quarters.
  • Tower Research Capital (TRC)'s Invacare Corporation position peaked at $359K in Q3 2020.
  • 72 funds tracked by Wall St. Rank held Invacare Corporation as of Q3 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.